Monday, 6 April 2009

Lanthanum Carbonate (Fosrenol) Chewable tablets 500 mg, 750 mg and 1gm: Innovator sued Natco

Innovator Shire has filed lawsuit (as confirmed by press release Here ) in the U.S. District Court for the Southern District of New York against Hyderabad based Natco Pharma Limited for infringement of Orange Book listed patents US5968976 and US7381428, listed for Lanthanum Carbonate (Fosrenol) Chewable tablets 500 mg, 750 mg and 1 gm
Earlier, Ippharmadoc reported Here that innovator confirmed receipt of Paragraph IV notice letter from Barr and Mylan. Innovator has already sued Barr and Mylan in District Court of the Southern District of New York as reported by us here. And Here

No comments:

web page statistics
Disclaimer: "IP Pharma Doc" blog is published for information purpose only. "IP Pharma Doc" blog contains no legal advice. I assume no legal responsibility for the views/information expressed here. “IP Pharma Doc” blog is my personal website and not edited by my employer, accordingly, no part of my blog should be attributed to my employer. All information on the present blog should be double checked for its accuracy and applicability. © Dr. Sarwal (2007)
 
eXTReMe Tracker